RituximabSerum sickness: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1815卷 / 1期

关键词：

D O I：

10.1007/s40278-020-81616-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：290 / 290

相关论文

共 50 条

[41] Ibritumomab tiuxetan/rituximabSerum sickness (first report with ibritumomab tiuxetan): case report
Reactions Weekly, 2008, 1186 (1) : 23 - 23
[42] RituximabSerum sickness: 3 case reports
Reactions Weekly, 2020, 1797 (1) : 207 - 207
[43] RituximabSerum sickness: 2 case reports
Reactions Weekly, 2024, 2025 (1) : 417 - 417
[44] RituximabSerum sickness: 3 case reports
Reactions Weekly, 2018, 1694 (1) : 381 - 381
[45] RituximabSerum sickness: 2 case reports
Reactions Weekly, 2010, 1283 (1) : 81 - 81
[46] Lenalidomide/rituximabSerum sickness, acute tumour flare reaction and neutropenia: case report
Reactions Weekly, 2013, 1470 (1) : 28 - 28
[47] Interferon beta-1a/rituximabSerum sickness and lack of efficacy: case report
Reactions Weekly, 2022, 1932 (1) : 332 - 332
[48] RituximabSerum sickness, acute respiratory distress syndrome and platelet refractoriness : case report
Reactions Weekly, 2022, 1909 (1) : 488 - 488
[49] RituximabSerum sickness reaction and neutropenia: 3 case reports
Reactions Weekly, 2012, 1425 (1) : 33 - 33
[50] RituximabSerum sickness-like symptoms: 2 case reports
Reactions Weekly, 2007, 1151 (1) : 27 - 27

← 1 2 3 4 5 →